| Insiders | Shares | % | Avg Price | Total $ | |
|---|---|---|---|---|---|
| Buys | 3 | +1.1M | 88.7% | $3.91 | +$4.32M |
| Sells | 4 | -141K | 11.3% | $2.17 | -$305K |
| Net | -1 | +964K | 77.4% | +$4.02M |
| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Nancy A. Simonian | Director | $367K | Oct 31, 2024 | ||
| Timothy Tyson | Director | $164K | Jun 5, 2024 | ||
| Marsha Fanucci | Director | $79.2K | Jun 5, 2024 | ||
| Wirth Peter | Director | $79.2K | Jun 5, 2024 | ||
| Deborah Dunsire | Director | $79.2K | Jun 5, 2024 | ||
| Sue Gail Eckhardt | Director | $79.2K | Jun 5, 2024 | ||
| Andrew M. Oh | Director | $79.2K | Jun 5, 2024 | ||
| Gerald E. Quirk | Chief Legal & Compliance Offic | $33.5K | -$10.3K | -23.5% | Nov 19, 2024 |
| Eric R. Olson | Chief Scientific Officer | $29.4K | Jul 17, 2023 | ||
| Mark J. Alles | Director | $28K | Sep 16, 2023 | ||
| Richard A. Young | Director | $22.4K | -$178K | -88.9% | Sep 16, 2024 |
| Srinivas Akkaraju | Director | $20.1K | +$4M | Sep 16, 2024 | |
| David Roth | Chief Medical Officer | $0 | -$108K | -100% | Nov 18, 2024 |
| Conley Chee | President & CEO, Director | $0 | +$161K | Nov 18, 2024 | |
| Jason Haas | Chief Financial Officer | $0 | +$161K | Nov 18, 2024 | |
| Kristin Stephens | Chief Development Officer | $0 | -$7.95K | -100% | Nov 18, 2024 |
| Phillip A. Sharp | Director | Jun 1, 2022 | |||
| Amir Nashat | Director | Jun 1, 2022 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|